Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study

BACKGROUND: During the end-of-life (EOL) phase of glioma patients, a rapid deterioration in neurological functioning may interfere with the oral intake of antiepileptic drugs (AEDs). We aimed to assess the feasibility of non-oral AED treatment in an out-of-hospital setting according to an expert-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Koekkoek, Johan A. F., Postma, Tjeerd J., Heimans, Jan J., Reijneveld, Jaap C., Taphoorn, Martin J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766209/
https://www.ncbi.nlm.nih.gov/pubmed/26404860
http://dx.doi.org/10.1007/s00520-015-2930-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766209/
https://www.ncbi.nlm.nih.gov/pubmed/26404860
http://dx.doi.org/10.1007/s00520-015-2930-3

Ejemplares similares